The stock price of BiomX Inc (AMEX: PHGE) has dropped by -12.18 compared to previous close of 0.58. Despite this, the company has seen a fall of -29.69% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-14 that BiomX Inc. (NYSE:PHGE ) Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ET Company Participants Marina Wolfson – Chief Financial Officer Jonathan Solomon – Chief Executive Officer Conference Call Participants Sara Nik – H.C. Wainwright Operator Greetings, and welcome to the BiomX Third Quarter 2024 Financial Results Conference Call.
Is It Worth Investing in BiomX Inc (AMEX: PHGE) Right Now?
Additionally, the 36-month beta value for PHGE is 1.31. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for PHGE is 11.20M and currently, short sellers hold a 0.21% ratio of that float. The average trading volume of PHGE on November 21, 2024 was 92.18K shares.
PHGE’s Market Performance
The stock of BiomX Inc (PHGE) has seen a -29.69% decrease in the past week, with a -45.85% drop in the past month, and a -62.46% fall in the past quarter. The volatility ratio for the week is 18.04%, and the volatility levels for the past 30 days are at 13.57% for PHGE. The simple moving average for the past 20 days is -31.79% for PHGE’s stock, with a -79.03% simple moving average for the past 200 days.
Analysts’ Opinion of PHGE
Many brokerage firms have already submitted their reports for PHGE stocks, with Ladenburg Thalmann repeating the rating for PHGE by listing it as a “Buy.” The predicted price for PHGE in the upcoming period, according to Ladenburg Thalmann is $25 based on the research report published on April 15, 2021 of the previous year 2021.
PHGE Trading at -43.00% from the 50-Day Moving Average
After a stumble in the market that brought PHGE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.05% of loss for the given period.
Volatility was left at 13.57%, however, over the last 30 days, the volatility rate increased by 18.04%, as shares sank -44.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.59% lower at present.
During the last 5 trading sessions, PHGE fell by -29.69%, which changed the moving average for the period of 200-days by -76.44% in comparison to the 20-day moving average, which settled at $0.7463. In addition, BiomX Inc saw -81.82% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PHGE starting from OrbiMed Israel BioFund GP Limi, who sale 24,344 shares at the price of $0.38 back on May 15 ’24. After this action, OrbiMed Israel BioFund GP Limi now owns 13,773,653 shares of BiomX Inc, valued at $9,280 using the latest closing price.
Oron Assaf, the Chief Business Officer of BiomX Inc, sale 10,914 shares at $0.37 during a trade that took place back on Nov 29 ’23, which means that Oron Assaf is holding 0 shares at $4,072 based on the most recent closing price.
Stock Fundamentals for PHGE
Current profitability levels for the company are sitting at:
- 125.07 for the present operating margin
- 11.77 for the gross margin
The net margin for BiomX Inc stands at 108.07. The total capital return value is set at -0.63. Equity return is now at value -72.95, with -36.11 for asset returns.
Based on BiomX Inc (PHGE), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -33.7. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -23.34.
Currently, EBITDA for the company is -22.82 million with net debt to EBITDA at -2.19. When we switch over and look at the enterprise to sales, we see a ratio of -73.35. The receivables turnover for the company is -0.27for trailing twelve months and the total asset turnover is -0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.17.
Conclusion
In conclusion, BiomX Inc (PHGE) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
